September 18, 2025

Smart Labels in Pharma: The Sustainable Cure for Counterfeiting and Waste

Smart labels are transforming pharma by cutting waste, reducing recalls, and fighting counterfeits — while helping companies comply with global regulations.

Introduction

The pharmaceutical industry faces two urgent challenges:

  • Counterfeit drugs and costly recalls that undermine patient safety and trust.
  • Sustainability mandates and consumer pressure to reduce packaging waste.

The solution? Smart labels powered by NFC (Near-Field Communication) and dynamic product data. These digital-first labels make each product verifiable, traceable, and updateable — reducing both environmental waste and the risk of fraud.

For pharmaceutical companies, smart labels are more than compliance tools. They are a competitive advantage in protecting patients and meeting regulatory goals.

How Smart Labels Reduce Waste

1. Eliminate Paper Inserts with ePIs

Printed leaflets in every pack generate tons of waste — and often go unread. A recent EU study found that removing paper inserts from hospital-only medicines could save 80 tons of paper annually.

With smart labels, patients and professionals simply tap their phone for the latest, localized instructions. Content can be updated in real time, reducing errors and waste.

👉 See how this aligns with our anti-counterfeit packaging solutions.

2. Reduce Recalls and Product Destruction

Recalls are often caused not by unsafe drugs but by outdated printed instructions.

With ForgeStop’s InfoTap™ smart labels, pharma companies can:

  • Push new dosage or safety alerts directly to the digital label
  • Deliver instant recall instructions to patients and pharmacists
  • Avoid destroying usable stock

For more, explore reducing pharmaceutical recalls with smart labels.

3. Enable Recyclability and Transparency

Pharmaceutical packaging often mixes plastics, foils, and adhesives that complicate recycling. Smart labels enable:

  • Digital disposal instructions based on region
  • Transparent product composition data for recyclers
  • Use of eco-friendly substrates like paper-based NFC inlays and bio-based adhesives

Learn more in our article on sustainable connected packaging.

Fighting Counterfeits in the Supply Chain

The WHO estimates 1 in 10 medicines in low- and middle-income countries is falsified — often with dangerous consequences.

Smart labels strengthen protection by enabling:

  • Instant consumer authentication with a smartphone
  • Distributor verification for tampering or diversion
  • Regulator traceability through serialization and UID logging

Every scan builds trust — and creates a secure audit trail.

Real-World Use Cases

  • ForgeStop Client: Eco-Friendly Patient Info
    Replaced a 12-page paper insert with a smart label → reduced paper, lowered shipping weight, and enabled instant recall updates.
  • Clinical Trials
    Sponsors are piloting dynamic labeling to update trial kits remotely. NFC smart labels deliver similar benefits at a lower cost than digital display labels.
  • ePIs in EMA/FDA Pilots
    Agencies in the EU, US, Japan, and Brazil are piloting digital patient information. NFC smart labels make compliance seamless — no app required.

Regulatory Changes Pharma Must Prepare For

Regulation Impact Timeline
EU PPWR Digital identifiers, recyclability disclosures, packaging waste reduction 2025–2026
ePI Initiatives (EMA/FDA) Shift from paper inserts to digital access for patient info Pilots now; mainstream by 2026+
Digital Product Passports (DPPs) Traceability + sustainability data at item level 2027+
GS1 / DSCSA / FMD Serialization and end-to-end track & trace Active now

Why ForgeStop Leads

ForgeStop’s InfoTap™ + BatchMaker platform delivers:

  • Dynamic product pages tailored by batch or region
  • Tamper-aware UID scans
  • Pharma-ready ePI hosting
  • Multilingual digital inserts
  • Custom recyclable label designs
  • Compliance-ready audit logs
  • Dark web and diversion monitoring
  • Integration with GS1 and SAP standards

Addressing Industry Concerns

Concern ForgeStop’s Solution
“NFC is too expensive.” Low-cost paper-based inlays keep unit costs down; savings from fewer recalls, logistics, and fraud offset investment.
“What about labeling compliance?” Aligned with EMA/FDA ePI initiatives and GS1 standards; audit logs and region-specific delivery built in.
“We need access control on digital content.” Region-locked, UID-locked, or batch-tied content with expiring tokens and role-based access.
“Will this scale for high-volume SKUs?” BatchMaker supports high-throughput encoding; rules and redirects can be automated at lot/batch/region level.

Final Word

Sustainability and anti-counterfeiting aren’t competing goals — they’re two sides of the same smart label.

ForgeStop helps pharma brands:

  • Cut waste (paper, packaging, recalls)
  • Build trust (counterfeit protection)
  • Stay compliant (ePI, serialization, ESG)
  • Connect directly with patients and pharmacists

👉 Contact ForgeStop to pilot smart labels for your next product line.

📘 Frequently Asked Questions

What industries already use smart labels?
Pharma, luxury goods, alcohol, and food sectors all leverage NFC smart labels for authentication and consumer engagement.
How do smart labels fight counterfeit medicines?
Each label is encrypted, tamper-aware, and scannable with any smartphone, allowing instant verification and traceability.
Are smart labels too expensive for high-volume products?
No. Low-cost paper-based NFC inlays make them scalable, and savings from reduced recalls and fraud offset costs.
Can smart labels help pharma companies comply with ePI and DPP regulations?
Yes, ForgeStop’s InfoTap™ smart labels align with EMA/FDA ePI pilots and upcoming EU Digital Product Passport requirements.
How do smart labels reduce waste in pharmaceuticals?
By eliminating paper inserts, lowering recall-driven destruction, and enabling recyclable packaging.